Respiratory Motion Receives CE Mark for ExSpiron™

Waltham, MA (May 26, 2016) - Respiratory Motion, Inc. today announced the CE Mark and full market release of ExSpiron™ for clinical use in CE countries, offering clinicians the only Patient Monitor Measuring Minute Ventilation.  

“Clinicians around the world rely on Minute Ventilation (MV) to make decisions on the respiratory status of patients on mechanical ventilators. ExSpiron™ is the only medical device able to provide this measurement in a patient monitor, offering immediate insight into a patients’ respiratory status than what is available in the market today”, stated Jenny Freeman, MD, CEO of Respiratory Motion. “We are excited to bring Minute Ventilation Monitoring to CE countries with the goal of helping clinicians more rapidly detect changes in respiratory status.”

See the full release here.

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Not a member? Sign up. Log Out